ahol888
Last month, Bayer donated three million tablets of Resochin to the US government in an effort to fight against Covid-19. Resochin is the brand name for hydroxychloroquine. Hydroxychloroquine is an anti-malarial drug that is used to treat lupus and rheumatoid arthritis. Thus, this medicine is very effective in dealing with parasites.
However, parasites and viruses work differently against a person. A parasite attaches to a host and takes all of the life out of the host. A virus attaches to a host and infects the host. That explains why hydroxychloroquine has been proven not to work against the coronavirus in clinical research done in France.
Actually, an even worse reason has been exposed as to why you should not take any of these Resochin tablets. Previous reports from the US Food and Drug Administration (FDA) detail that plants in Pakistan and in India in which the tablets were made had shoddy equipment. Some of the problems include “failure in manufacturing processes, falsification of records, and falsification of inspection documents.”
-
Do you smell a rat?
-
1Yes
-
2No
-
People in this situation are trying everything. But no one warned them how this medicine works.
Yes, there is no warning at all. Some things are working, but the research will take time.
I don’t think it has an effect. But it’s a crime to play with the fate of people this way in this pandemic
It’s horrible, but people are looking to make a whole bunch of money on this pandemic.
Is this the drug Donald Trump recommended?? I read he was recommending it because he wanted to boost the sales of the enterprise that produces this drug as they were his friends. Many people were buying this drug.
Yes, this is the one that was recommended solely because he has stock in the company called Novartis. Also, Bayer was looking to cash in with the donation of the tablets because they have lost over $30 billion (USD) in market value after buying Monsanto in 2018. Even during this outbreak, people are still looking to capitalize on the misfortune of others.